Management of locally advanced adenocarcinoma of the pancreas

Hematology/Oncology Clinics of North America

Volumn 16, Issue 1, 2002, Pages 95-103

  Ryan, David P ^a   Willett, Christopher G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DIPYRIDAMOLE; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; MITOMYCIN; PACLITAXEL; RADIOSENSITIZING AGENT; STREPTOZOCIN;

CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUCED DISEASE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADIOSENSITIZATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; STEVENS JOHNSON SYNDROME; TREATMENT OUTCOME;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DOXORUBICIN; FLUOROURACIL; HUMANS; MITOMYCINS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; PACLITAXEL; PANCREATECTOMY; PANCREATIC NEOPLASMS; RADIATION-SENSITIZING AGENTS; RADIOISOTOPE TELETHERAPY; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; STREPTOZOCIN;

EID: 0036266232     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(01)00009-0     Document Type: Review

References (39)

1. T for assessment of pancreatic and periampullary cancer
2. Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: Results of a feasibility study
3. Effect of hospital volume on in-hospital mortality with pancreaticoduodenectomy
4. Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer
5. Potentially resectable pancreatic adenocarcinoma: Spiral CT assessment with surgical and pathologic correlation
6. Cancer of the pancreas
7. Diagnosis and staging of pancreatic adenocarcinoma with dynamic computed tomography
8. Thin-section contrast-enhanced computed tomography accurately predicts the resectabilily of malignant pancreatic neoplasms
9. High-dose preoperative external beam and intraoperative irradiation for locally advanced pancreatic cancer
10. A multi-institutional comparative trial of radiation therapy alone and in combination with 5-fluorouracil for locally unresectable pancreatic carcinoma
11. Radiation therapy combined with Adriamycin or 5-fluorouracil for the treatment of locally unresectable pancreatic carcinoma
12. Phase II studies of drug combinations in advanced pancreatic carcinoma: Fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil
13. Treatment of locally unresectable carcinoma of the pancreas: Comparison of combinedmodality therapy (chemotherapy plus radiotherapy) to chemotherapy alone
14. Cancer statistics, 2002
15. Intraoperative irradiation: Current and future status
16. A phase I study of preoperative gemcitabine with radiation therapy followed by postoperative gemcitabine for patients with localized, resectable pancreatic adenocarcinoma
17. Impact of laparoscopic staging in the treatment of pancreatic cancer
18. Combined modality therapy for stage II and stage III pancreatic carcinoma
19. Treatment of locally unresectable cancer of the stomach and pancreas: A randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil
20. Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluoroucil, leucovorin and cisplatin
21. Radiosensitization of pancreatic cancer cells by 2′.2′difluoro-2′-deoxycytidine
22. Survival following pancreaticoduodenectomy with resection of the superior mesenterie-portal vein confluence for adenocarcinoma of the pancreatic head
23. Local staging of pancreatic cancer: Criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT
24. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer
25. Therapy of locally unrescetable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation · 5-fluorouracil
26. Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas
27. External and intraoperative radioperative for resectable and unresectable pancreatic cancer: Analysis of survival rates and complications
28. Laparoscopy in the staging of pancreatic cancer
29. External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer
30. Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: A phase study
31. Paclitaxel and concurrent radiation for locally advanced pancreatic cancer
32. Metabolism of 2′.2′-difluoro-2′-deoxycytidine and radiation sensitization of haman colon carcinoma cells
33. Mechanism of radiosensitization by 2′,2′-difluorodeoxycytidine
34. Radiosensitization of hmnan solid tumor cell lines with gemcitabine
35. Eastern Cooperative Ontology Group phase trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: A regimen with unexpected early toxicity
36. Intraoperative radiation therapy of pancreatic carcinoma: A report of RTOG-8505
37. Resection of locally advanced pancreatic cancer after downstaging with continuous-infusion 5-fluorouracil, mitomycin-C, leucovorin, and dipyridamole
38. Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: A phase I Eastern Cooperative Oncology Group Trial
39. Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma